Delayed dynamics of migratory response to CTLA-4 blockade reveals a mechanistic view on potential T cells reinvigoration following immune checkpoint blockade
F. Safaeifard, S. P. Shariatpanahi, B. Golieai, A. R. Aref, M.-H. Foroughmand-Araabi, S. Goliaei, C. Ruegg
Abstract
Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) receptors, two clinically relevant targets for immunotherapy of cancer, are negative regulators of in immune cell activation and migration. However, optimizing therapeutic outcomes still requires fundamental research to reach a comprehensive insight into the coherent function of immune regulators. Here, we investigated the statistical dynamics of T cells migration as a measure of the functional response to these pathways in an experimental setup of immune checkpoint blockade. For this purpose, we used a previously developed 3-dimensional organotypic culture of patient-derived tumor spheroids. Experiment-based dynamical modeling remarked distinct characteristics of the receptors regulation followed through with the modification of their proportions in the immune modulation. We demonstrated that time-delayed kinetics of PD-1 activation just overrides its relatively more efficient cell-level function which potentially makes an operative contribution to the functional dominance of CTLA-4 in the tumor microenvironment. Simulation results showed good agreement with data for tumor cells reduction and active immune cells count observed in each experiment. These analyses propose a new mechanistic view on relative immunogenicity of PD-1 and CTLA-4 inhibitors manifested in literature and point the possible inherent obstacles in checkpoint inhibition-based immunotherapy of cancer to address in the future. SignificanceEx vivo monitoring of temporal response to PD-1 and CTLA-4 in the closure of T cell movement dynamics and elucidating their feasible commitment to the kinetic constraints at cell-level resolution. Delayed dynamics of migratory response to CTLA-4 inhibition revealed a mechanistic view on potential T cell reinvigoration following immune checkpoint blockade.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell level temporal profiling of tumour-reactive T cells under immune checkpoint blockade
J. Hassan, E. Appleton, … M. Ono·bioRxiv·Jul 19, 2022
- Antigen and Checkpoint Receptor Recalibration of T Cell Receptor Signal Strength
T. A. E. Elliot, E. K. Jennings, … D. Bending·bioRxiv·Mar 2, 2021
- Soluble CTLA-4 raises the threshold for T-cell activation and modulates anti-tumour immunity
P. T. Kennedy, E. L. Saulters, … L. N. Dahal·bioRxiv·Jun 5, 2023
- OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
G. Beyrend, T. C. van der Sluis, … R. Arens·bioRxiv·Dec 24, 2021
- Therapeutic Blockade of Type 2 Cytokines and PD1 Unleashes Anti-Tumor Immunity Through Coordinated Reprogramming of Innate and Adaptive Immune Surveillance
Thomas Fabre, Eleanore Hendrickson, … Alex Barron·bioRxiv·Sep 26, 2025
- Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response
A. Gangaev, E. A. Rozeman, … P. Kvistborg·bioRxiv·Dec 15, 2020